Clinical Activity of Pralatrexate in Patients With Cutaneous T-Cell Lymphoma Treated With Varying Doses of Pralatrexate
Overview
Overview
Journal
Clin Lymphoma Myeloma Leuk
Publisher
Elsevier
Specialty
Oncology
Date
2018 Sep 6
PMID
30181105
Citations
2
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Pralatrexate for refractory mycosis fungoides in two Japanese patients.
Teraishi M, Oguro T, Kusume E, Kobashi H, Sano H, Fujioka A J Dermatol. 2021; 48(5):667-671.
PMID: 33454985 PMC: 8248132. DOI: 10.1111/1346-8138.15761.
Kitazume K, Akagawa Y, Wada S, Suzuki T, Fujita A Case Rep Oncol. 2019; 12(2):529-536.
PMID: 31427947 PMC: 6696769. DOI: 10.1159/000501070.